The mitogen-activated protein kinases (MAPKs) are a family of serine/threonine kinases that play an essential role in signal transduction by modulating gene transcription in the nucleus in response to changes in the cellular environment. They include the extracellular signal-regulated protein kinases (ERK1 and ERK2); c-Jun N-terminal kinases (JNK1, JNK2, JNK3); p38s (p38a, p38b, p38c, p38d) and ERK5. The molecular events in which MAPKs function can be separated in discrete and yet interrelated steps: activation of the MAPK by their upstream kinases, changes in the subcellular localization of MAPKs, and recognition, binding and phosphorylation of MAPK downstream targets. The resulting pattern of gene expression will ultimately depend on the integration of the combinatorial signals provided by the temporal activation of each group of MAPKs. This review will focus on how the specificity of signal transmission by MAPKs is achieved by scaffolding molecules and by the presence of structural motifs in MAPKs that are dynamically regulated by phosphorylation and protein-protein interactions. We discuss also how MAPKs recognize and phosphorylate their target nuclear proteins, including transcription factors, co-activators and repressors and chromatin-remodeling molecules, thereby affecting an intricate balance of nuclear regulatory molecules that ultimately control gene expression in response to environmental cues.
Introduction
Members of the family of mitogen-activated protein kinases (MAPKs) are proline (Pro)-targeted serine/ threonine kinases that play an essential role in signal transduction by modulating gene transcription in the nucleus in response to changes in the cellular environment. MAPKs control key cellular functions, including proliferation, differentiation, migration and apoptosis, and participate in a number of disease states including chronic inflammation and cancer (Schaeffer and Weber, 1999; Davis, 2000; Kyriakis and Avruch, 2001; Pearson et al., 2001; Zarubin and Han, 2005) . In humans, there are at least 11 members of the MAPK superfamily, which can be divided into six groups based on sequence similarity: the extracellular signal-regulated protein kinases (ERK1 and ERK2); c-Jun N-terminal kinases (JNK1, JNK2, JNK3); p38s (p38a, p38b, p38g, p38d); ERK5 (ERK5); ERK3s (ERK3, p97 MAPK, ERK4) and ERK7s (ERK7, ERK8) (Schaeffer and Weber, 1999; Pearson et al., 2001) . Each group of MAPKs can be stimulated by a separate protein kinase cascade that includes the sequential activation of a specific MAPK kinase kinase (MAPKKK) and a MAPK kinase (MAPKK), which in turn phosphorylates and activates their downstream MAPKs . These signaling modules have been conserved throughout evolution, from plants, fungi, nematodes, insects to mammals (Widmann et al., 1999) . Among the MAPK pathways, the mechanisms governing the activation of ERKs have been the most extensively studied, as impeding the function of ERKs prevents cell proliferation in response to a variety of growth factors (Pages et al., 1993) , and its overactivity is sufficient to transform cells in culture (Mansour et al., 1994) . Indeed, the wealth of available biochemical, biophysical and structural information on the mechanisms involved in ERK activation and the nature of the intervening signaling routes has enabled the use of theoretical and computational approaches to study MAPK activation, thus becoming a prototype for the emerging field of systems biology (Schoeberl et al., 2002; Hornberg et al., 2005) .
MAPKs require their dual phosphorylation in two conserved threonine (Thr) and tyrosine (Tyr) residues within their activation loop for their full activation (Canagarajah et al., 1997; Pearson et al., 2001) . These phosphorylations sites are separated by only one amino acid, thereby defining a tripeptide motif, Thr-X-Tyr. Historically, the identity of the amino acid located between the two phospho-acceptor sites has defined the different groups of MAPKs. For example, ERKs (ERK1, ERK2 and ERK5) exhibit Thr-glutamic (Glu)-Tyr in their activation loop; JNKs (JNK1-3) Thr-Pro-Tyr; and p38 MAPKs (p38a-d) Thr-glycine (Gly)-Tyr (reviewed in Widmann et al., 1999; Pearson et al., 2001) . The ability of specific MAPKKs to recognize different MAPKs depends in part on these distinct tri-peptide motifs, thus, contributing to the specificity of the molecular mechanisms by which each MAPK family can be activated. This ensures that cells mount an appropriate response to extracellular stimulation.
Upon activation, MAPKs phosphorylate and control the activity of key cytoplasmic molecules and nuclear proteins, which in turn can regulate gene expression. Ultimately, the resulting gene expression program will depend on the integration of the combinatorial signals provided by the temporal activation of each of the MAPK families. In particular, the precise nature of the extracellular stimuli and the repertoire of molecules available in each cell type can determine the localization, timing, intensity and duration of the activation of each member of the MAPK family, thus influencing the resulting gene expression patterns and therefore the biological responses. For example, mitogens acting on tyrosine kinase growth factor receptors and G proteincoupled receptors (GPCRs) activate ERK1/2 (Ullrich and Schlessinger, 1990; Gutkind, 2000) , whereas JNK and p38 MAPKs respond preferentially to cellular stress signals (Davis, 2000; Zarubin and Han, 2005) . ERK5, also called big map kinase (BMK) because its size is nearly double of the other members of the MAPK family can be activated by both growth factors and stress (Nishimoto and Nishida, 2006 ).
The structure of MAPKs
As described in additional articles in this issue, structural and biophysical aspects of MAPKs have been studied in great detail; members of ERK1/2, p38 and JNK groups have been all crystallized alone or in combination with substrates, scaffolds, targets and inhibitors (Lee et al., 2006b) . These studies have provided a molecular understanding of the canonical MAPK domain structure. Briefly, MAPKs are composed by two domains, an N-terminal domain formed largely by b-sheets and two helices, aC and aL16, and a C-terminal domain that is mostly helical, with four short b-strands that contain several residues involved in catalysis (Chen et al., 2001) . The catalytic site, where the ATP and two magnesium ions bind, is at the junction between these two domains. A flexible linker maintains the proper orientation between the N-and C-terminal domains, and therefore, its conformation is important for the enzymatic activity. A 50-residue insertion, the MAPK insertion, located in the Cterminal domain and a extension of this domain that spans the whole protein, including the aL16 helix, distinguishes MAPKs from other proteins of the kinase superfamily (Chen et al., 2001 ; Figure 1 ).
MAPKs bind their upstream regulators (MAPKKs) and downstream targets by surface interactions that are achieved through docking motif binding sites that are outside of the catalytic domain (Biondi and Nebreda, 2003; Tanoue and Nishida, 2003) . Emerging studies in the last few years have provided compelling evidence that these binding sites for docking motifs play a key role in determining the substrate specificity of MAPKs (Biondi and Nebreda, 2003; Tanoue and Nishida, 2003; Dimitri et al., 2005; Ho et al., 2006) . The best described docking motif is known as docking site for ERK and JNK (DEJL) or D motif (Chang et al., 2002; Lee et al., 2004; Callaway et al., 2005; Zhou et al., 2006) which posses the general pattern (Arg/Lys) 1À2 -(X) 2-6 -+ A -X-+ B , where + A and + B are hydrophobic residuesleucine (Leu), isoleucine (Ile) or valine (Val). Crystal structures of MAPK complexes with peptides derived from upstream and downstream targets having these DEJL motifs (e.g., ERK2 with MAPK phosphatase 3 (MK3) or with the hematopoietic tyrosine phosphatase (HePTP)); p38a with the transcription factor myocyte enhancer factor (MEF)2 or the p38 MAPKK, MKK3B; and JNK1 with the scaffold Jun interacting protein 1 (JIP1) (Chang et al., 2002; Heo et al., 2004; Zhou et al., 2006; Liu et al., 2006b) have revealed that the MAPK binding site for the DEJL motif is similar among the different groups of MAPKs, comprising an hydrophobic grove between helices aD, aE and the b7-b8 reverse turn and an acidic patch that binds the positive amino acids within the DEJL motif of the partner protein (Figure 1 ).
MAPKs phosphorylate many transcription factors in their transcriptional transactivation domain (TAD) and therefore enhance their transcriptional activity (Ofir et al., 1990; Derijard et al., 1994; Livingstone et al., 1995; Yang et al., 1999; Tanos et al., 2005) . Most transcription factor TADs are unstructured in solution (Campbell et al., 2000) and have docking motifs that allow them to bind with high specificity to MAPKs. Indeed, the importance of these docking regions for the MAPK recognition of their target transcription factors was clearly shown in the case of p38 MAPK using chimeric molecules where the p38-targeting region of MEF2A, which includes its DEJL motif, was fused to the TAD of Elk-1 (which is phosphorylated by JNK and ERK1/2) and c-Jun (which is a target for JNK). These chimeras were efficiently phosphorylated by p38a and p38b, accordingly, reciprocal MEF2A chimeras in which their docking region was replaced for that of c-Jun were phosphorylated by JNK, but not by any of the p38 isoforms (Yang et al., 1999) . A second docking motif often found in MAPK substrates, such as the kinase suppressor of Ras (KSR) and the transcription factors Elk1 (p62 ternary complex factor) and SAP-1, has the amino-acid sequence phenylalanine (Phe)-X-Phe-Pro and was termed docking site for ERK FXFP (DEF) domain (Jacobs et al., 1999; Galanis et al., 2001) . The DEF-binding region in ERK2 was mapped to the P þ 1 site, the aF helix and the MAPK insert . Interestingly, a study conducting disruptive mutations of each of the ERK2 docking binding regions has shown that they can act independently, and therefore, may contribute to the regulation of distinct signaling events in vivo (Dimitri et al., 2005) .
Owing to the strong structural similarity among MAPKs, it has been difficult to determine how the specificity of signal transmission is achieved. In this regard, the comparison of the structure of different MAPK complexes has revealed that changes in the amino-acid composition of MAPK docking binding regions can determine the binding selectivity (Chang et al., 2002; Heo et al., 2004; Zhou et al., 2006; Liu et al., 2006b) (Figure 1) . Moreover, recent studies have provided insights into the dynamic conformational changes occurring on MAPKs upon binding to upstream activators, scaffolds and downstream targets (Heo et al., 2004; Hoofnagle et al., 2004; Lee et al., 2005; Zhou et al., 2006) , which can also contribute to the signaling specificity of each MAPK module. In turn, the binding of MAPKs to the docking motifs of their interacting partners may cause MAPKs to change their conformation and expose their catalytic domains, thereby becoming more accessible to MAPKKs, phosphatases and transcription factors (Zhou et al., 2006) . Dynamic changes have also been observed in the structure of ERK1/2 upon phosphorylation and ATP binding that were not previously appreciated by X-ray crystallographic studies (Hoofnagle et al., 2001 Lee et al., 2004) . It is now clear that the study of the dynamic regulation of MAPKs is of key importance to elucidate fully how MAPKs function. In this regard, efforts aimed at elucidating these changes in the structure of MAPKs will likely need the combination of experimental techniques with theoretical simulations that allow a detailed understanding of protein dynamics (Lindorff-Larsen et al., 2005). Signal specificity is achieved by the recognition of docking motifs present in partner proteins such as the DEJL motif ((Lys/Arg) 1-2 -(X) 2-6 -+ A -X-+ B , where + A and + B are hydrophobic residues-Leu, Ile, or Val). The DEJL binding region is similar among the different groups of MAPKs, comprising an hydrophobic groove between helices aD, aE, the b7-b8 reverse turn and an acidic patch. Crystal structures of MAPKs (gray ribbons, yellow colored amino acids correspond to the MAPK docking binding region.) bound to small peptides corresponding to the DEJL motif of (b) MKK3B (PDB code 1LEW), (c) JIP1 (PDB code 1UKH) and (d) MEF2A (PDB code 1LEZ) are shown (peptides are depicted in surface rendering colored by amino-acid type: polar amino acids in green, hydrophobic in white, negatively charged in red and positively charged in blue.)
Signaling to the nucleus through MAPKs
The molecular events in which MAPKs function can be separated in discrete and yet interrelated steps; the activation of MAPKs by MAPKKs, the change in subcellular localization of MAPKs, and the recognition, binding and phosphorylation of MAPK downstream targets (Figure 2 ). Detail studies of each one of these steps have revealed an increasingly complex mechanism that is far from being fully understood. The first step includes the binding of specific MAPKKs to the kinase-docking site and the dual phosphorylation of the key Thr and Tyr residues located in the activation loop. Although both phosphorylation events are required to activate MAPKs fully , this phosphorylation appears to be sequential, and monophosphorylated MAPKs may perform distinct biological roles (Zhou and Zhang, 2002b) . In fact, the simulation of MAPK networks suggests that the ultrasensitivity observed in MAPK cascades arise as a consequence of this two step phosphorylation process (Fitzgerald et al., 2006) . Moreover, scaffold proteins, which bind signaling molecules thereby creating functional modules that ensure the specificity of signal transmission, can increase the efficiency of the MAPK activation process, therefore modulating both the duration and intensity of the MAPK signal output. Upon stimulation by mitogens, tyrosine kinase growth factor receptors, such as EGF receptors, activate small GTPases of the Ras and Rho family through specific guanine-nucleotide exchange factors. Ras and Rho GTPases, in turn control the activity of independent MAPK cascades. For example, whereas Ras stimulates the Raf/MEK/ ERK signaling pathway, Rac, a Rho-related guanine triphosphate (GTP)-binding protein, activates a distinct biochemical route leading to the stimulation of JNK. The specificity of signal transmission can be achieved by protein-protein interactions and scaffold proteins that organize key components of signaling pathways into functional modules. For example, the scaffolding protein JNK interacting protein 1 (JIP1) forms a molecular complex with JNK and its upstream activators, such as MKK7 and MLK3, thus facilitating the rapid activation of JNK by Rac (scaffold proteins for ERK are described in the text). Activated -phosphorylatedMAPKs then translocate to the nucleus where they regulate gene expression. As depicted, MAPK can phosphorylate the transactivating domain of transcription factors, including activating transcription factor (ATF)2, Jun proteins and TCF, which are bound to their response elements within the promoter region of early response genes, such as c-jun and c-fos. MAPKs subsequently modulate the activity of the newly synthesized proteins c-Jun and c-Fos that can dimerize to form AP-1 complexes, which bind the promoter region of growth promoting genes, including c-myc. Delayed gene expression is favored by changes in the structure of the chromatin. Chromatin remodeling can be regulated by MAPKs through the activation of downstream kinases such as MSK and ribosomal S6 kinase (RSK)2 that phosphorylate the N-terminal tail of histones thereby tagging them for further post-translational modifications. The timely activation of early and delayed response genes by the phosphorylation of pre-existing and newly synthesized transcription factors and the subsequent regulation of the activity of chromatin remodeling proteins illustrates how rather than acting in isolation, MAPKs act in a coordinated fashion as part of a highly interconnected signaling network. Ultimately, the integration of MAPK-initiated signals help to orchestrate the appropriate cellular response to environmental cues.3
Most of our knowledge of scaffold originates from studies on the yeast MAPK, (Elion, 2001) , but the discovery of numerous scaffold proteins in higher eukaryotes has provided a new perspective to this field. The family of JIP1/2/3/4, which regulate both the JNK and p38 kinase cascades (Morrison and Davis, 2003) are the best characterized MAPK scaffolds in mammalian cells. Some of these scaffolding molecules perform very specific functions. For example, the osmosensing scaffold for mitogen activated protein kinase kinase (MEKK)3 is specific for p38, and binds to the kinases MEKK3 and MKK3 thereby enabling the rapid activation of p38 in response to sorbitol-induced hyperosmolarity (Uhlik et al., 2003) . A recent study has proposed that MEK5 can act as a scaffold for the ERK5 signaling pathway (Nakamura et al., 2006) . MEK-partner 1 (MP1), KSR and b-arrestins, can all act as scaffolds for the ERK cascade (reviewed in Morrison and Davis, 2003) .
Upon activation many MAPKs, including ERK1/2, dissociate from their scaffolding molecules and MAPKKs, and translocate from the cytoplasm to the nucleus (Gonzalez et al., 1993; Lenormand et al., 1998) by a still not fully understood mechanism. In particular, ERK2 can enter the nucleus by passive diffusion or by an active transport process depending on its status of aggregation, monomeric or dimeric, respectively (Khokhlatchev et al., 1998; Adachi et al., 1999) . Stimulation of cells with ultraviolet irradiation induced transient translocation of JNK1 (Cavigelli et al., 1995) . Similarly, osmotic shock induces the nuclear localization of p38 (Ben-Levy et al., 1998) . In the case of ERK5, a phosphorylation-dependent mechanism that inhibits nuclear export and therefore causes its nuclear import and retention has been reported (Kondoh et al., 2006) .
Once localized to the nucleus, MAPKs bind their target molecules through docking-mediated interactions, followed by the recognition and phosphorylation of the Ser/Thr-Pro phospho-acceptor motif in their substrates. In this regard, the most widely used mechanism by which MAPKs regulate gene expression is by the phosphorylation of transcription factors (Ofir et al., 1990; Minden et al., 1994; Livingstone et al., 1995) . However, the precise mechanism by which MAPKs phosphorylate their targets and how, in turn, the phosphorylation of transcription factors results in their enhanced transcriptional activity is yet to be fully elucidated. As many transcription factors are unstructured in solution, crystallographic studies have proven to be difficult, as reflected by the fact that only one structure of a MAPK/transcription factor complex has been solved to date, the complex of p38a with a peptide of MEF2 bound to its docking site (Chang et al., 2002) (Figure 1) . Moreover, very little is known about the reaction mechanism catalyzed by MAPKs. Most of our knowledge on the kinase-phospho-transfer reactions are based on studies investigating the catalytic subunit of cAMP-dependent protein kinase A (PKA) (Yang et al., 2004) , a kinase that is distantly related to MAPKs. Similarly, studies on cAMP response element binding protein (CREB) suggest that its phosphorylation in Ser 133 by PKA stimulates the transcriptional activity of CREB by enhancing the binding affinity of its TAD towards transcriptional co-activators, such as CREB binding protein (CBP) (Chrivia et al., 1993) . However, only in this case a clear role of the added phosphate group in enhancing the binding affinity of the CREB-TAD for CBP has been established (Chrivia et al., 1993; Radhakrishnan et al., 1997) . This may not represent a general mechanism, as for example, a biochemical study has reported that the binding of c-Jun to the kinaseinduced domain interacting domain (KIX) domain of CBP is independent of the phosphorylation status of c-Jun (Campbell and Lumb, 2002) . In fact, the phosphorylation of the c-Jun TAD by JNK may enhance its transcriptional activity indirectly, as it increases the stability of c-Jun by decreasing its ubiquitin-dependent degradation (Musti et al., 1997) .
The Ser/Thr-Pro motif, present in all downstream targets of MAPKs, exhibits a unique equilibrium between its trans and cis conformation. These sites are recognized by prolyl isomerases, such as Pin, which can accelerate the changes in the conformation of the phosphorylated Ser/Thr residues therefore modulating the activity of transcription factors (Monje et al., 2005; Wulf et al., 2005) . In addition, in several cases the targets of MAPKs have multi phosphorylation sites, which may act in a synergistic fashion to promote gene expression (Smeal et al., 1991; Cruzalegui et al., 1999; Monje et al., 2003; Tanos et al., 2005) . On the other hand, although less frequent, MAPKs can also inhibit the activity of transcription factors, for example by promoting their retention in the cytoplasm upon phosphorylation. The active dephosphorylation of these factors is then required for their migration to the nucleus to stimulate gene transcription. As examples, phosphorylation of the transcription factors mothers against decapentaplegic (SMAD)1 and nuclear factor of activated T cells (NFAT)4 by ERK1/2 (Kretzschmar et al., 1997) and JNK (Chow et al., 1997) , respectively, causes their cytoplasmic retention and therefore the inhibition of their transcriptional activity.
Regulation of gene expression through ERK1/2 ERK1/2, also known as p44 MAPK and p42
MAPK
, respectively, were the first MAPKs to be described in mammals (Rossomando et al., 1989) . Two isoforms, ERK1 and ERK2, are expressed in mammalian cells with 83% of sequence identity. ERK2 is the bestcharacterized member of the group. ERK2 is activated by most growth factor receptors. For example, binding of epidermal growth factor (EGF) to the extracellular domain of the EGF receptor (EGFR) leads to receptor dimerization and the consequent tyrosine phosphorylation of several EGFR targets, including the EGFR itself (Ullrich and Schlessinger, 1990) . A multitude of signaling proteins are then recruited to the activated receptors through phosphotyrosine-specific recognition motifs (Schlessinger and Ullrich, 1992; Buday and Downward, 1993). These proteins include Grb2, which in turn will bind son of sevenless, drosophila homolog 1 (SOS) that stimulates the exchange of guanine diphosphate (GDP) bound to Ras for GTP, and Ras then initiates a protein kinase cascade that includes, sequentially, Raf, MEK1/2 and ERK2 (reviewed in Ullrich and Schlessinger, 1990; Pearson et al., 2001) . Upon dual phosphorylation by MEK1/2, the activity of ERK2 is enhanced, with a 50 000-fold increase in k cat (Prowse et al., 2000) .
ERK activity is terminated by the dephosphorylation of the Thr-Glu-Tyr motif by specific phosphatases. However, the actual mechanism and identity of the ERK phosphatases is still a matter of discussion. For example, hematopoietic protein-tyrosine phosphatase (HePTP), mitogen-activated protein kinase phosphatase-3 (MKP3), and protein serine/threonine phosphatase 2A (PP2A) can all act as ERK2 phosphatases (Zhou et al., 2002a) . Although ERK2 activity can be terminated by Tyr 185 dephosphorylation with high efficiency and fidelity by HePTP (Huang et al., 2004 ), PP2A regulates a wide variety of cellular signal transduction pathways, including the Raf1-MEK1/2-ERK1/2 signaling pathway at multiple steps, and can act as a negative or positive regulator of ERK1/2 activity (Zhou et al., 2002a; Ory et al., 2003) .
The mammalian ERK MAPK pathway is implicated in multiple physiological processes, including cell proliferation, differentiation and survival . The activation of ERK1/2 induces proliferative signals that may contribute to normal and cancerous cell growth (Cowley et al., 1994; Mansour et al., 1994) . Consistently, aberrant activation of the ERK pathway, often owing to mutation in genes encoding molecules regulating ERK1/2, such as Ras, is a frequent event in many human cancer types (Hoshino et al., 1999) . In this regard, the identification of Ras as a key downstream target of growth factors receptors and a master switch initiating the activity of a cascade of cytoplasmic kinases that culminate with the activation of ERK1 and ERK2 represented a breakthrough in cancer biology, and provided an insight on how the aberrant function of this small GTPase may contribute to the malignant conversion of cancer cells.
ERKs phosphorylate and stimulate the activities of many nuclear transcription factors, thus regulating gene expression (Table 1) . Perhaps, the best example is the activation of activator protein-1 (AP-1) transcription factors. Members of the Jun family of transcription factors (c-Jun, JunB and JunD) form homodimers or heterodimers among them or with Fos family members (c-Fos, FosB, Fra1 and Fra2), to make up AP-1 protein complexes (Angel and Karin, 1991) . MAPKs control both the expression of members of the AP-1 family as well as their activity by the post-translational processing of pre-existing or newly synthesized AP-1 proteins. For example, activation of ERK1/2 leads to the coordinated stimulation of c-fos expression by acting on transcription factors bound at the c-fos promoter, such as Elk-1 that is also known as ternary complex factor (TCF) (Whitmarsh et al., 1995) , and by the subsequent post-translational modification of c-Fos by the direct multisite phosphorylation of the c-Fos TAD that greatly enhances c-Fos activity and stability (Murphy et al., 2002; Monje et al., 2003) . On the other hand, Elk-1 is one of the best-studied targets of the ERK cascade, as ERKs phosphorylate Elk-1 in several sites thereby increasing its transcriptional activity (Gille et al., 1992; Cruzalegui et al., 1999) .
c-Myc is a transcription factor involved in the control of cell proliferation, differentiation and apoptosis (Eisenman, 2001 ). Activation of the Ras/MEK/ERK JNK 1,2 c-Jun (Pulverer et al., 1991) ATF-2 (Gupta et al., 1995; Davis, 2000) ELK-1 (Whitmarsh et al., 1995) JunD (Gupta et al., 1995; Davis, 2000) ELK-3 (Ducret et al., 2000) p53 ( (Wang et al., 1996; Zarubin and Han, 2005) p38b ATF-2 (Jiang et al., 1996; Zarubin and Han, 2005) c-Fos (Tanos et al., 2005) MEF2 A, C (Yang et al., 1999) ELK-1 (Yang et al., 1998) pathway induces the stabilization of c-Myc, and this ERK2-dependent phosphorylation on Ser 62 is in turn required for the Ras-induced stabilization of c-Myc (Sears and Nevins, 2002) . The Sp1 protein, one of the first eukaryotic transcription factors to be identified and cloned, plays a central role in the expression of many genes implicated in cell cycle progression and tumor growth (Li et al., 2004 
Nuclear signaling by JNKs
The JNK MAPKs, also known as stress-activated MAPK (Davis, 2000) , are characterized by the dual phosphorylation motif Thr-Pro-Tyr within their activation loop. JNK was initially discovered by its ability to phosphorylate the N-terminal transactivating domain of c-Jun at Ser-63 and Ser-73. JNK is implicated in several physiological processes including, apoptosis, proliferation and differentiation (Briata et al., 2005) . Three JNK-coding genes have been identified in mammals, JNK1, JNK2 and JNK3 (Davis, 2000) . The JNK1 and JNK2 genes and their alternatively spliced variants are expressed ubiquitously, but the JNK3 gene has a more restricted expression pattern, with highest levels in brain and testis (Davis, 2000) .
The mechanism by which the JNK group of MAPKs is activated by external stimuli is not as well understood as in the case of ERKs. Following the distinct pattern of activation of ERK and JNK by cellular receptors, an unexpected discovery was that as Ras regulates ERKs, two members of the Rho family of GTPases, Rac1 and Cdc42, initiate an independent kinase cascade regulating JNK activity (Coso et al., 1995) . These findings provided direct evidence of a role for Rho GTPases in transcriptional regulation, in addition to their best studied cytoskeletal effects. Potential targets of these GTPases in the JNK pathway include members of the MEKK group (MEKK1-4), the mixed-lineage protein kinase group (MLK1, MLK2, MLK3, dual leucine zipper bearing kinase (DLK) and leucine zipper-bearing kinase (LZK)), the apoptosis signal-regulating kinase (ASK) group (ASK1 and ASK2), TGF-b-activated kinase (TAK)1 and TPL2 (Davis, 2000) . Two protein kinases that activate JNK have been identified (MKK4 and MKK7) (Davis, 2000) . Even although both MKK4 and MKK7 can activate JNK by dual phosphorylation on Thr and Tyr, MKK4 appears to preferentially phosphorylate Tyr 185 and MKK7 Thr 183 (Gerwins et al., 1997; Lisnock et al., 2000) .
One of the genes whose expression is under tight control by JNK is the c-jun gene. MAPKs of the JNK family rapidly phosphorylate c-Jun proteins already present in the cell in response to extracellular stimuli (Pulverer et al., 1991) . Once phosphorylated, c-Jun becomes active and induces the transcription of the c-jun gene, leading to the autoregulatory induction of c-jun (Angel et al., 1988) . Of interest, although ERKs do not phosphorylate c-Jun in its TAD, by virtue of their ability to stimulate c-fos expression and to activate c-Fos, ERKs may act synergistically with JNKs to enhance AP-1 activity. JNK also phosphorylates other AP-1 proteins, including JunB, JunD and ATF2 (Davis, 2000) . Another interesting case of crosstalk between MAPK cascades is c-Myc. In addition to ERK1/2 (see above), JNK also phosphorylates c-Myc at Ser 62 and Thr 71 and regulates its pro-apoptotic function (Noguchi et al., 1999) .
The role of ERK5 in gene expression regulation ERK5, also known as BMK1, is a MAPK distantly related to ERK1/2 which contains a Thr-Glu-Tyr motif in its trans-activation loop, similar to that of ERK1/2 (Zhou et al., 1995) . This kinase is larger than other MAPKs (B88 kDa), in fact its C-terminal domain is unique and believed to be responsible for its distinct biological activities (Buschbeck and Ullrich, 2005) . Upon stimulation ERK5 is activated specifically by a member of the MEK family of kinases known as MEK5 (Kato et al., 1997) , and several upstream kinases have been thus far identified that can promote ERK5 activation by phosphorylating MEK5, such as COT, MEKK3 and MEKK2, in response to diverse stimuli (reviewed in Nishimoto and Nishida, 2006) . MEK5 mediated ERK5 activation leads to an ERK5 autophosphorylation in its unique C-terminal domain (Nishimoto and Nishida, 2006) , whose ultimate effect is still under investigation. For example, the presence of two proline-rich domains in the ERK5 C-terminus provides a link between ERK5 and the actin cytoskeleton in the cytoplasm, whereas the same domain contains a nuclear localization signal and is responsible for the targeting and activation of several transcription factors that act downstream from ERK5 (Yan et al., 2001; Nishimoto and Nishida, 2006) . The transcription factors that are directly activated by ERK5 phosphorylation include MEF2A (Marinissen et al., 1999) , MEF2C (Kato et al., 1997; Marinissen et al., 1999) , c-Fos and Fra-1 (Terasawa et al., 2003) , and Sap1a (Kamakura et al., 1999) , which can regulate AP-1 function. Indeed, ERK5 plays a critical role in the regulation of c-jun expression by controlling the activity of MEF-2 transcription factors that bind to a MEF-2 response element proximal to the c-jun AP-1 site within the c-jun promoter (Marinissen et al., 1999) . Other transcription factors regulated by ERK5 include CREB (Watson et al., 2001) , Ets-1 (Dwivedi et al., 2002) , and cMyc (English et al., 1998) , some of which are also shared by ERK1/2, reflecting a degree of redundancy that exists among MAPK targets (Nishimoto and Nishida, 2006) . ERK5 activity plays a critical role in DNA synthesis upon the release from a cell cycle block in HeLa cells and by serum stimulation in MCF10A cells (Kato et al., 1998) . In cultured cortical progenitor cells, ERK5 is instead involved in neuronal differentiation (Liu et al., 2006a) . Embryos from ERK5 knockout mice die on day E9.5 and E10.5 of gestation, presenting phenotypes defective for normal angiogenesis, head formation, cardiac development and placenta (Yan et al., 2003) . Targeted deletion of ERK5 in adult mice results in failure of endothelial integrity, leading to generalized hemorrhages (Hayashi et al., 2004) . Gene array data from knockout and control embryos suggest that the role for ERK5 in angiogenesis may involve the transcriptional regulation of lung Kru¨ppel-like factor, whose expression is reduced in ERK5À/À embryos (Sohn et al., 2005) . In the same line, very recent work has shed some light about the contribution of ERK5 to global gene expression regulation as compared to that of ERK1/2 (Schweppe et al., 2006) .
The p38 family of MAPKs (p38a, p38b, p38c, p38d) in gene transcription control
The family of p38 kinases consists on four isoforms named p38a, p38b, p38g and p38d (Zarubin and Han, 2005) . Despite that all p38s share a Thr-Gly-Tyr dualphosphorylation motif in their activation loop, remarkable differences exist among these members, being in general p38a more similar to p38b than to p38g and p38d (Hu et al., 1999; Waetzig et al., 2002) . In this regard, p38a and p38b isoforms are sensitive to treatment with pyridinylimidazole and share similar substrates such as ATF-2 and MAPKAPK2 (Zarubin and Han, 2005) . Moreover, it has been proposed that JNK-associated leucine zipper protein (Lee et al., 2002) specifically scaffolds p38a and p38b to cell surfacelinked complexes in differentiating myocites (Takaesu et al., 2006) and JIP2 does so with MEKK3 and p38a in adipocites (Robidoux et al., 2005) . Instead p38g and p38d isoforms are not responsive to pyridinylimidazole treatment, and they do not activate the same transcription factors than p38a and p38b. p38g and p38d may even exert opposite effects on AP-1 activation (Pramanik et al., 2003) . The upstream p38 kinases, such as MKK3 and MKK6, are able to phosphorylate all p38 isoforms, suggesting that the specific activation of each p38 isoform, and thus the consequent regulation of downstream transcription factors, may rely on differences in p38 expression patterns in each cell lineage or even specific stage of cellular differentiation (reviewed in Zarubin and Han, 2005) . Targeted disruption of p38a is embryonic lethal, and developing embryos display defective erythropoiesis (Tamura et al., 2000) and placental defects (Adams et al., 2000) . p38s are particularly sensitive to the stimulation by exposure of cells to endotoxins, including lipopolysaccharide (LPS) (Lai et al., 2003) , and cell stress signals (Conrad et al., 1999) , and participate in inflammatory responses by regulating the expression of COX-2, tumor necrosis factor-a (TNF-a), IL-1b and IL6 (reviewed in Zarubin and Han, 2005) , to name but a few p38-regulated genes. p38s can also participate in DNA-damage induced cell death, particularly by phosphorylating the tumor suppressor protein p53 in Ser 33, thus contributing to the chemosensitivity of tumor cells (Sanchez-Prieto et al., 2000) depending on their mutational status in p53. Another interesting role for p38 is the regulation of mRNA stability and mRNA translation by phosphorylating mRNA-binding proteins (reviewed in Dean et al., 2004; Zarubin and Han, 2005) , such as tristetraprolin through MK2 (Hitti et al., 2006) and eukaryotic elongation factor 2 kinase (Knebel et al., 2001) , being the latter more specific for the p38d isoform. This mechanism of translational control that impinges on cis-acting elements in the mRNA of certain genes, including TNF-a, may contribute to some of the biological functions in which p38s act, such as inflammation and myocite differentiation (Zarubin and Han, 2005) .
Signal integration in the nucleus: spatiotemporal regulation of gene expression by MAPKs
The simplest model of how extracellular stimuli communicate to the nucleus and control gene expression involves the receptor-mediated activation of signal transducing molecules, such as small GTP-binding proteins of the Ras and Rho family which, in turn, control the activity of parallel MAPK cascades resulting in the phosphorylation of critical nuclear transcription factors. However, most cell surface receptors stimulate a number of highly interconnected cytoplasmic signaling routes that lead to a temporally distinct pattern of activation of members of the MAPK superfamily. Ultimately, these kinases will reach the nucleus and thus control gene expression by changing the phosphorylation status of nuclear proteins, including transcription factors, coactivators and repressors and chromatinremodeling molecules, thereby affecting an intricate balance of nuclear regulatory molecules.
One still poorly understood process is how MAPK coordinate gene expression with chromatin remodeling. Most of the cellular DNA is compacted into nucleosomes, in which 146 bp of DNA are wrapped 1.7 turns around a protein octamer of two each of the core histones H3, H4, H2A and H2B (Luger et al., 1997) , linked by a variable length of DNA associated with the linker histone H1 (Blank and Becker, 1996) . Whereas the core region of histones is associated with the DNA, their N-terminal tails, which are extremely basic because of numerous lysine and arginine residues, are the target of post-translational modifications that control the compaction of the nucleosome and thus the accessibility of the DNA to regulatory molecules and transcription factors (Lee et al., 1993) . In fact, covalent posttranslational modifications of the histone N-terminal tail, for example, by phosphorylation, methylation and acetylation, appears to be a pre-requisite for some transcription factors to bind their target DNA sequences, and thus to control -activate or repressgene expression (Figure 2 ; Jenuwein and Allis, 2001; Bernstein and Hake, 2006) . Although consensus MAPK histone phosphorylation sites have not been described in vivo, MAPKs can activate histone-phosphorylating kinases (Cheung et al., 2000; Zhong et al., 2001) . For example, ERK1/2 and p38a, -b can provoke changes in chromatin structure (Li et al., 2001; Illi et al., 2005; Schmeck et al., 2005) most likely owing to the activation of downstream kinases such as MSK1/2 (Saccani et al., 2002; Soloaga et al., 2003; Lee et al., 2006a; Vicent et al., 2006) or RSK2 (Cheung et al., 2000) that phosphorylate the N-terminal tail of histones. A surprising recent finding is that MAPKs bind to specific actively transcribed genes, as documented in yeast (Pokholok et al., 2006) , reinforcing the idea that MAPKs participate actively in chromatin remodeling, perhaps explaining the observation that MAPKs such as p38a and ERK1/2 bind cellular DNA as judged by the use of chromatin immunoprecipitation assays in mammalian cells (Simone et al., 2004; Vicent et al., 2006) .
In addition to regulate the status of phosphorylation of histones, MAPKs can also induce changes in chromatin by phosphorylating transcription factors that acetylate histones directly, such as ATF-2 (Kawasaki et al., 2000) , or indirectly, as for c-Myc (Sears et al., 1999; Frank et al., 2003) . These transcription factors may also serve as good examples of how the spatiotemporal regulation of gene expression by MAPKs can be achieved. ATF-2 as well as Jun proteins are constitutively bound to the promoter region of the early response gene c-jun, (van Dam et al., 1993; Marinissen et al., 2004) . Similarly, members of the TCF family are persistently bound to the serum response element (SRE) site within the c-fos promoter in an open chromatin context, which allows the MAPK-dependent phosphorylation of TCF to promote the immediate transcription of the early response gene c-fos (Herrera et al., 1989) . In contrast, c-Myc binding to DNA depends on chromatin context, and chromatin remodeling may be a prerequisite for the access of c-myc to its target genes (Guccione et al., 2006) (Figure 2) . These events may be highly coordinated. For example, mitogens acting on GPCRs and polypeptide growth factor receptors promote the expression of c-jun by stimulating transcription factors bound to the c-jun promoter, including ATF2 and Jun proteins through JNK, and MEF2 through p38 and ERK5 (Marinissen et al., 1999 (Marinissen et al., , 2004 . Concomitantly, these mitogens promote the expression of c-fos by activating TCF bound to the c-fos SRE through ERK, JNK, and p38, whereas changes in the actin cytoskeleton stimulates the serum responsive factors (Miralles et al., 2003) . Once transcribed, newly synthesized c-Jun and c-Fos are phosphorylated by JNK and ERK, thereby enhancing AP-1 dependent gene expression. Interestingly, a phylogenetically conserved AP-1-responsive element was recently identified in the promoter of c-myc that recruits AP-1 protein in vivo, thus providing a likely mechanism by which cell surface receptors may stimulate c-myc expression through the JNK-and ERK-dependent activation of AP-1 transcription factors (Chiariello et al., 2001; Iavarone et al., 2003) . In turn, activation of RSK2 and MSK1 by ERKs and p38s may promote histone phosphorylation, which promotes chromatin remodeling and enables c-Myc and other transcription factors to bind their target DNA sequences, thereby ultimately promoting the re-initiation of DNA-synthesis by regulating the expression of cell cycle regulating proteins. Indeed, the timely activation of early and delayed response genes by the phosphorylation of transcription factors and chromatin remodeling proteins illustrates nicely that rather than acting in isolation, MAPKs act in a coordinated fashion as part of highly interconnected signaling networks to orchestrate the appropriate cellular response to environmental stimuli. Future studies in this area may soon facilitate achieving a systems-level understanding of the functional organization of MAPK networks, how the strength and duration of MAPK-initiated signals are integrated to elicit specific gene expression programs, including those involved in normal and aberrant cell proliferation, and ultimately, how perturbation of MAPK-regulated functions results in human disease, including cancer.
